Concepedia

Kenneth D. Bromberg

KD

19

Publications

2.4K

Citations

17

H-Index

2001

Active since

Affiliations

AbbVie (United States)(Current)

Vanderbilt University

Icahn School of Medicine at Mount Sinai

University of Pennsylvania

Sanford Burnham Prebys Medical Discovery Institute

Kenneth D. Bromberg is an author at AbbVie (United States) specializing in medicine, cell biology, and natural sciences.

Top concepts

Publications per year

2001–2021

19

Publications

19

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Loren Lasko, Clarissa G. Jakob, Rohinton Edalji et al. · Nature · 2017 · 813 citations · Full text

, , +8

Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome

Brian T. Weinert, Takeo Narita, Shankha Satpathy et al. · Cell · 2018 · 511 citations · Full text

, , +3

Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition

Simon J. Hogg, Olga Motorna, Leonie A. Cluse et al. · Molecular Cell · 2021 · 157 citations · Full text

A Two-drug Model for Etoposide Action against Human Topoisomerase IIα

Kenneth D. Bromberg, Alex B. Burgin, Neil Osheroff · Journal of Biological Chemistry · 2003 · 142 citations · Full text

Design Logic of a Cannabinoid Receptor Signaling Network That Triggers Neurite Outgrowth

Kenneth D. Bromberg, Avi Ma’ayan, Susana R. Neves et al. · Science · 2008 · 140 citations · Full text

, , +20

Rows per page

1–5 of 19